Techniques And Strategies For GDC-0449 Which Only A Few Are Aware Of

Матеріал з HistoryPedia
Версія від 10:26, 11 грудня 2016, створена Iranchild1 (обговореннявнесок) (Створена сторінка: A diagnosis of undifferentiated adrenal tumor with rhabdoid features was rendered. Figure 5 Grossly the adrenal mass is pale yellowish solid with lobular patter...)

(різн.) ← Попередня версія • Поточна версія (різн.) • Новіша версія → (різн.)
Перейти до: навігація, пошук

A diagnosis of undifferentiated adrenal tumor with rhabdoid features was rendered. Figure 5 Grossly the adrenal mass is pale yellowish solid with lobular pattern and centrally myxoid degeneration and geographic necrosis. Figure 6 Histopathology of tumor. (a) The tumor cells are arranged in solid sheets and show pleomorphic nuclei with prominent nucleoli (H&E, ��100). (b) Some tumor cells have eccentric nuclei with abundant cytoplasm (H&E, ��200). Two days after tumor resection, the patient reported dyspnea and developed hypoxia; chest CT confirmed the presence of multifocal pulmonary thromboembolism, bilateral pneumonia, and pulmonary infarction. Mechanical ventilation, intensive care, and administration of antibiotics were continued, but the patient showed pneumonia aggravation, acute kidney selleck inhibitor injury, and fungemia, with no signs of improvement. The patient's legal guardian refused to continue intensive care and transferred the patient to another hospital for supportive treatment. The patient died 2 months after his initial diagnosis. 3. Discussion Pheochromocytoma, along with paraganglioma, is a chromaffin neuroendocrine tumor that secretes catecholamine, which mostly manifests characteristic symptoms including headache, hypertension, and palpitation. However, approximately 10% of patients may show no symptoms, and careful evaluation is necessary, as pheochromocytoma can be life threatening if left undiagnosed [1, 7]. A diagnosis of pheochromocytoma is obtained primarily by biochemical testing, whereas if catecholamine learn more excess is seen, imaging studies are performed in order to localize the tumor. Imaging can also be considered in cases with ambiguous results from biochemical testing and in patients with genetic disposition or previous history of pheochromocytoma [9]. Even with normal results from biochemical testing, it may be difficult to rule out pheochromocytoma, and in about 10% of pheochromocytoma and paraganglioma patients with a succinate dehydrogenase subunit B gene mutation have normal results in biochemical tests. Moreover, there have been recent reports of asymptomatic pheochromocytoma in patients who showed no excess of catecholamine during biochemical Quinapyramine testing due to adrenal incidentaloma [10�C12]. Currently, 123I-MIBG scintigraphy is widely used as a functional imaging tool. It has high sensitivity and specificity in diagnosis of neuroendocrine tumors, which, along with anatomical imaging tools such as CT and MRI, is recommended in the diagnosis and localization of pheochromocytoma [9]. In addition, in patients diagnosed with pheochromocytoma through biochemical testing, the combined use of MRI and 123I-MIBG scintigraphy has a sensitivity and positive predictive value of 100%; even in patients with symptomatic pheochromocytoma and normal urinary catecholamine metabolites, positive uptake in 123I-MIBG scintigraphy is seen.